Key Findings: Most common: Nausea (43%), diarrhea (33%), vomiting (21%) Unique to retatrutide: Dysesthesia (20.9% @ 12mg in TRIUMPH-4, 8.8% @ 9mg) Discontinuation rate: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 (general obesity population) compared to semaglutide 6.9%, tirzepatide 6.2% Good news: Most side effects peak during dose escalation and improve significantly after week 16 Management: Slow titration, dietary modifications, and proper timing dramatically reduce severity Understanding the Three Categories of Side Effects 1
Staying consistent with taking your medication avoids the need to go through this process again
A significant presence of a GSTP1-1 allelic variant (the GSTP1*C allelic variant) was found in late-onset AD patients 52
0.6% acetic acid solution Required for certain peptides like IGF-1 LR3, IGF-1 DES, and NAD+ that degrade in both bacteriostatic and sterile water
Biological Role of GLP-1 Introduction to GLP-1 GLP-1 is an incretin hormone primarily produced in the L-cells of the small intestine in response to food intake
The kidneys help get rid of extra B12